A 39-year-old man with with human immunodefi ciency virus (HIV) infection and a CD4 cell count of 528 × 10 6 /L without treatment was referred for evaluation of periarticular, indurated, erythematous papules and
nodules on the knees and elbows and purpuric lesions on the ankles (Figure 1) . He has had recurrent fever, arthralgia, and mild constitutional symptoms during the past month. He also reported a diagnosis of polyclonal immunoglobulin A gammopathy.
Punch biopsy of the purpuric lesions was performed, and histologic study showed leukocytoclastic vasculitis with eosinophilic necrosis of the epithelium.
Treatment with a systemic corticosteroid was started. The purpuric lesions disappeared after 3 weeks of therapy, but the nodules over the extensor surface of both knees showed no improvement (Figure 2) . Subsequent biopsy of late-stage lesions (3 months after the start of therapy) demonstrated perivascular fi brosis with small, persistent foci of vasculitis, and confi rmed the diagnosis of HIV-associated nodular erythema elevatum diutinum (EED). Antiretroviral therapy was started in addition to intralesional corticosteroids and topical dapsone 5% gel, with resolution of the lesions 1 month later.
THE CLINICAL PICTURE
doi:10.3949/ccjm.83a.15128 FIGURE 1. The patient had purpuric lesions on the ankles and indurated, erythematous papules and nodules on the knees. 
Oral dapsone is the treatment of choice but is not as effective in late-stage fi brotic lesions NODULES ON THE KNEES ■ ERYTHEMA ELEVATUM DIUTINUM
EED is an uncommon chronic dermatosis, classifi ed as a fi brosing form of leukocytoclastic vasculitis and characterized clinically by violaceous papules, plaques, and nodules, usually distributed acrally and symmetrically over extensor surfaces. The histopathologic picture depends on the stage of the lesion. Features of leukocytoclastic vasculitis are found in earlystage lesions, while a fi brotic replacement of the dermis with small persistent foci of vasculitis is typical of late-stage lesions.
EED has clinical and histopathologic similarities to Sweet syndrome, but EED is distinguished from neutrophilic dermatosis by vasculitis. 1 In HIV-infected patients, it is important to include pruritic papular eruption in the differential diagnosis. It is characterized by chronic bilaterally symmetric pruritic papules on the trunk and extremities and is the most common cutaneous noninfectious manifestation of HIV.
The clinical presentation of EED may also be easily confused with Kaposi sarcoma and bacillary angiomatosis.
■ AN EMERGING HIV-RELATED DERMATOSIS
EED is emerging as a specifi c HIV-associated dermatosis, with 20 cases reported in the medical literature as of this writing. 3 The cause of EED is not known, but it is often associated with streptococcal infection, monoclonal IgA gammopathy, hematologic malignancy, cryoglobulinemia, rheumatoid arthritis, and autoimmune disease. 3 The stimulus could be immune-complex deposition in blood vessels triggered by HIV infection, or by another infection acting as an antigenic stimulus. 4 The nodular variant of EED is even rarer, but it evolves most often in HIV-positive individuals. 5, 6 Oral dapsone is the treatment of choice but is less effective in late-stage fi brotic lesions. 7 Treatment courses tend to be long and recurrence is common. 8 Intralesional, topical, and oral corticosteroids, topical dapsone 5% gel, 9 tetracycline and nicotinamide, sulfonamides, colchicine, chloroquine, and surgical excision are other options.
Our patient's presentation reminds us to consider EED in HIV-infected patients and illustrates the importance of histologic diagnosis to differentiate EED from assumed Kaposi sarcoma in patients with HIV. EED can also be the fi rst clinical sign of HIV infection. It is important to rule out underlying disorders such as HIV infection, because directed therapy is often the best management.
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